Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

NCT00536861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Brain Metastases

Interventions

DRUG: erlotinib

Sponsor

Amsterdam UMC, location VUmc